Jump to content

Carcinogenic bacteria

From Wikipedia, the free encyclopedia

Bacteria involved in causing and treating cancers

Cancer bacteria are bacteria infectious organisms that are known or suspected to cause cancer.[1] While cancer-associated bacteria have long been considered to be opportunistic (i.e., infecting healthy tissues after cancer has already established itself), there is some evidence that bacteria may be directly carcinogenic. Evidence has shown that a specific stage in cancer can be associated with bacteria that is pathogenic.[2] The strongest evidence to date involves the bacterium H. pylori and its role in gastric cancer.[1]

Oncoviruses are viral agents that are similarly suspected of causing cancer.

Known to cause cancer

[edit]

Helicobacter pylori colonizes the human stomach and duodenum. It is described as a Class 1 carcinogen.[2] In some cases it can cause stomach cancer[3][4] and MALT lymphoma.[5] Animal models have demonstrated Koch's third and fourth postulates for the role of Helicobacter pylori in the causation of stomach cancer.[6] The mechanism by which H. pylori causes cancer may involve chronic inflammation, or the direct action of some of its virulence factors, for example, CagA has been implicated in carcinogenesis.[7] Another bacteria that is in this genus is Helicobacter hepaticus, which causes hepatitis and liver cancer in mice.[8]

Chronic inflammation

[edit]

Chronic inflammation contributes to the pathogenesis of several types of malignant diseases, but it is particularly important for H. pylori.[9] Following a H. pylori infection many circulating immune cells are recruited to the infection site including neutrophils. [10] To destroy the pathogens, neutrophils produce substances with antimicrobial activities such as oxidants like reactive oxygen species (ROS) and reactive nitrogen species (RNS).[11] H. pylori can survive the induced oxidative stress by producing antioxidant enzymes such as e.g., catalase.[12] However, the overproduction of ROS and RNS induces various types of DNA damage in the infected gastric cells.[12]At the same time H. pylori is known to down-regulate major DNA repair pathways.[13] As a result, genomic and mitochondrial mutations accumulate, leading to genomic instability - a well-known Hallmark of Cancer [14] - in the gastric cells.[13]

CagA

[edit]

The virulence factor CagA in H. pylori has been linked to the development of gastric cancer.[15] Once CagA is injected into the cytoplasm it can change the gastric cell signaling in both a phosphorylation-dependent and -independent manner. [11] Phosphorylated CagA affects cell adhesion, spread and migration[16] but can also induce the release of the proinflammatory chemokine IL-8.[15] Additionally, interactions of the CRPIA motif in non-phosphorylated CagA were shown to lead to the persistent activation of the PI3K/Akt pathway, a pathway that is often overly active in many human cancers.[17][18] This leads to the activation of the pro-inflammatory NF-κB and β-catenin pathways as well as increased gastric cell proliferation.[17] Furthermore, CagA has also been found to increase tumor suppressor gene hypermethylation and thereby inhibiting the tumor suppressor genes.[19] This is achieved by upregulating the methyltransferase DNMT1 via the AKT–NF-κB pathway.[19][20] Lastly, CagA also induces the expression of the enzyme spermine oxidase (SMOX) that converts spermine to spermidine.[11] As a by-product H2O2 is produced which causes ROS accumulation and contributes to the oxidative stress that the gastric cells experience during chronic inflammation.[11]

[edit]

A number of bacteria have associations with cancer, although their possible role in carcinogenesis is unclear.

Bacteria Suggested link
Salmonella Typhi, Paratiphi A, Typhimurium is associated with gallbladder cancer.[21][22]
Streptococcus bovis is associated with colorectal cancer.[23][24]
Chlamydia pneumoniae is associated with lung cancer.[23][25]
Mycoplasma may also have a role in the formation of different types of cancer.[26][27]
Helicobacter pylori has been linked with certainty to stomach cancer [28] and may be related to MALT lymphoma, and has also been associated to oral cancer.[2] but may also protect certain individuals from esophageal cancer.[23]
Porphyromonas gingivalis is associated with esophageal cancer, colorectal cancer, pancreatic cancer.[29]
Fusobacterium nucleatum is associated with esophageal cancer, colorectal cancer, pancreatic cancer.[29]
Escherichia coli is associated with colorectal cancer.[29]
Salmonella spp. is associated with colorectal cancer.[29]
Enterotoxigenic Bacteroides fragilis is associated with colorectal cancer.[29]
Chlamydia trachomatis in concert with HPV infection is associated with cervical cancer.[29]
Streptococcus anginosus is associated with esophageal cancer.[30]
Streptococcus mitis is associated with esophageal cancer.[30]
Ruminococcus is associated with colorectal cancer when under aerobic conditions.[31]

Salmonella Typhi has been linked to gallbladder cancer but may also be useful in delivering chemotherapeutic agents for the treatment of melanoma, colon and bladder cancer.[23] Bacteria found in the gut may be related to colon cancer but may be more complicated due to the role of chemoprotective probiotic cancers.[32] Microorganisms and their metabolic byproducts, or impact of chronic inflammation, may also be linked to oral cancers.[33]

The relationship between cancer and bacteria may be complicated by different individuals reacting in different ways to different cancers.[23]

History

[edit]

In 1890, the Scottish pathologist William Russell reported circumstantial evidence for the bacterial cause of cancer.[34] In 1926, Canadian physician Thomas Glover reported that he could consistently isolate a specific bacterium from the neoplastic tissues of animals and humans.[35] One review summarized Glover's report as follows:

The author reports the isolation of a pleomorphic organism from various types of cancer which can be grown in pure cultures in its several phases. He produced a serum from it which has given remarkable results in a series of 50 reported cases. This is very important, if true. We suppose the Cancer Society will give an opinion later on the reliability of the findings."[36]

Glover was asked to continue his work at the Public Health Service (later incorporated into the National Institutes of Health) completing his studies in 1929 and publishing his findings in 1930.[37] He asserted that a vaccine or anti-serum manufactured from his bacterium could be used to treat cancer patients with varying degrees of success.[37] According to historical accounts, scientists from the Public Health Service challenged Glover's claims and asked him to repeat his research to better establish quality control.[38] Glover refused and opted to continue his research independently; not seeking consensus, Glover's claims and results led to controversy and are today not given serious merit.[39]

In 1950, a Newark-based physician named Virginia Livingston published a paper claiming that a specific Mycobacterium was associated with neoplasia.[40] Livingston continued to research the alleged bacterium throughout the 1950s and eventually proposed the name Progenitor cryptocides as well as developed a treatment protocol.[41] Ultimately, her claim of a universal cancer bacterium was not supported in follow up studies. In 1990 the National Cancer Institute published a review of Livingston's theories, concluding that her methods of classifying the cancer bacterium contained "remarkable errors" and it was actually a case of misclassification - the bacterium was actually Staphylococcus epidermidis.[39]

Other researchers and clinicians who worked with the theory that bacteria could cause cancer, especially from the 1930s to the 1960s, included Eleanor Alexander-Jackson, William Coley, William Crofton, Gunther Enderlein, Franz Gerlach, Josef Issels, Elise L'Esperance, Milbank Johnson, Arthur Kendall, Royal Rife, Florence Seibert, Wilhelm von Brehmer, and Ernest Villequez.[42] Alexander-Jackson and Seibert worked with Virginia Livingston. Some of the researchers published reports that also claimed to have found bacteria associated with different types of cancers.[43][44][45][46][47][48]

See also

[edit]

References

[edit]
  1. ^ a b Alfarouk KO, Bashir AH, Aljarbou AN, Ramadan AM, Muddathir AK, AlHoufie ST, et al. (22 February 2019). "The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management". Frontiers in Oncology. 9: 75. doi:10.3389/fonc.2019.00075. PMC 6395443. PMID 30854333.
  2. ^ a b c Khajuria N, Metgud R (2015). "Role of bacteria in oral carcinogenesis". Indian Journal of Dentistry. 6 (1): 37–43. doi:10.4103/0975-962X.151709. PMC 4357077. PMID 25767359.
  3. ^ Egi Y, Ito M, Tanaka S, Imagawa S, Takata S, Yoshihara M, et al. (May 2007). "Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia". Japanese Journal of Clinical Oncology. 37 (5): 365–369. doi:10.1093/jjco/hym029. PMID 17578895.
  4. ^ Peter S, Beglinger C (2007). "Helicobacter pylori and gastric cancer: the causal relationship". Digestion. 75 (1): 25–35. doi:10.1159/000101564. PMID 17429205. S2CID 21288653.
  5. ^ Morgner A, Bayerdörffer E, Neubauer A, Stolte M (March 2000). "Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease". Microscopy Research and Technique. 48 (6): 349–356. doi:10.1002/(SICI)1097-0029(20000315)48:6<349::AID-JEMT5>3.0.CO;2-7. PMID 10738316. S2CID 9289825.
  6. ^ Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M (September 1998). "Helicobacter pylori infection induces gastric cancer in mongolian gerbils". Gastroenterology. 115 (3): 642–648. doi:10.1016/S0016-5085(98)70143-X. PMID 9721161.
  7. ^ Hatakeyama M, Higashi H (December 2005). "Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis". Cancer Science. 96 (12): 835–843. doi:10.1111/j.1349-7006.2005.00130.x. PMC 11159386. PMID 16367902.
  8. ^ Suerbaum S, Josenhans C, Sterzenbach T, Drescher B, Brandt P, Bell M, et al. (June 2003). "The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus". Proceedings of the National Academy of Sciences of the United States of America. 100 (13): 7901–7906. Bibcode:2003PNAS..100.7901S. doi:10.1073/pnas.1332093100. PMC 164685. PMID 12810954.
  9. ^ Coussens LM, Werb Z (December 2002). "Inflammation and cancer". Nature. 420 (6917): 860–867. Bibcode:2002Natur.420..860C. doi:10.1038/nature01322. PMC 2803035. PMID 12490959.
  10. ^ White JR, Winter JA, Robinson K (May 2015). "Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes". Journal of Inflammation Research. 8: 137–147. doi:10.2147/JIR.S64888. PMC 4540215. PMID 26316793.
  11. ^ a b c d Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C (February 2023). "Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms". International Journal of Molecular Sciences. 24 (3): 2895. doi:10.3390/ijms24032895. PMC 9917787. PMID 36769214.
  12. ^ a b Kalisperati P, Spanou E, Pateras IS, Korkolopoulou P, Varvarigou A, Karavokyros I, et al. (2017-02-27). "Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis". Frontiers in Genetics. 8: 20. doi:10.3389/fgene.2017.00020. PMC 5326759. PMID 28289428.
  13. ^ a b Machado AM, Figueiredo C, Seruca R, Rasmussen LJ (August 2010). "Helicobacter pylori infection generates genetic instability in gastric cells". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1806 (1): 58–65. doi:10.1016/j.bbcan.2010.01.007. PMID 20122996.
  14. ^ Hanahan D, Weinberg RA (March 2011). "Hallmarks of cancer: the next generation". Cell. 144 (5): 646–674. doi:10.1016/j.cell.2011.02.013. PMID 21376230.
  15. ^ a b Hatakeyama M (March 2014). "Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis". Cell Host & Microbe. 15 (3): 306–316. doi:10.1016/j.chom.2014.02.008. PMID 24629337.
  16. ^ Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. (October 2002). "Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites". Proceedings of the National Academy of Sciences of the United States of America. 99 (22): 14428–14433. Bibcode:2002PNAS...9914428H. doi:10.1073/pnas.222375399. PMC 137900. PMID 12391297.
  17. ^ a b Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, et al. (January 2009). "Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation". Cell Host & Microbe. 5 (1): 23–34. doi:10.1016/j.chom.2008.11.010. PMID 19154985.
  18. ^ Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, et al. (August 2021). "The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review". Cancers. 13 (16): 3949. doi:10.3390/cancers13163949. PMC 8394096. PMID 34439105.
  19. ^ a b Zhang W, Xu J (December 2017). "DNA methyltransferases and their roles in tumorigenesis". Biomarker Research. 5 (1): 1. doi:10.1186/s40364-017-0081-z. PMC 5251331. PMID 28127428.
  20. ^ Zhang BG, Hu L, Zang MD, Wang HX, Zhao W, Li JF, et al. (March 2016). "Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development". Oncotarget. 7 (9): 9788–9800. doi:10.18632/oncotarget.7125. PMC 4891084. PMID 26848521.
  21. ^ Boccellato F, Meyer TF (June 2015). "Bacteria Moving into Focus of Human Cancer". Cell Host & Microbe. 17 (6): 728–730. doi:10.1016/j.chom.2015.05.016. PMID 26067598.
  22. ^ Scanu T, Spaapen RM, Bakker JM, Pratap CB, Wu LE, Hofland I, et al. (June 2015). "Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma". Cell Host & Microbe. 17 (6): 763–774. doi:10.1016/j.chom.2015.05.002. PMID 26028364.
  23. ^ a b c d e Mager DL (March 2006). "Bacteria and cancer: cause, coincidence or cure? A review". Journal of Translational Medicine. 4 (1): 14. doi:10.1186/1479-5876-4-14. PMC 1479838. PMID 16566840.
  24. ^ Gold JS, Bayar S, Salem RR (July 2004). "Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy". Archives of Surgery. 139 (7): 760–765. doi:10.1001/archsurg.139.7.760. PMID 15249410.
  25. ^ Kocazeybek B (August 2003). "Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study". Journal of Medical Microbiology. 52 (Pt 8): 721–726. doi:10.1099/jmm.0.04845-0. PMID 12867569.
  26. ^ Ning JY, Shou CC (May 2004). "[Mycoplasma infection and cancer]". AI Zheng = Aizheng = Chinese Journal of Cancer. 23 (5): 602–604. PMID 15142464.
  27. ^ Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, et al. (September 2009). Bruggemann H (ed.). "Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells". PLOS ONE. 4 (9): e6872. Bibcode:2009PLoSO...4.6872N. doi:10.1371/journal.pone.0006872. PMC 2730529. PMID 19721714.
  28. ^ Traulsen J, Zagami C, Daddi AA, Boccellato F (2021-03-01). "Molecular modelling of the gastric barrier response, from infection to carcinogenesis". Best Practice & Research. Clinical Gastroenterology. 50–51: 101737. doi:10.1016/j.bpg.2021.101737. PMID 33975688. S2CID 233900318.
  29. ^ a b c d e f Yusuf K, Sampath V, Umar S (February 2023). "Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients". International Journal of Molecular Sciences. 24 (4): 3110. doi:10.3390/ijms24043110. PMC 9958598. PMID 36834525.
  30. ^ a b Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H, et al. (July 2004). "Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers". Cancer Science. 95 (7): 569–574. doi:10.1111/j.1349-7006.2004.tb02488.x. PMC 11159681. PMID 15245592.
  31. ^ Tsuruya A, Kuwahara A, Saito Y, Yamaguchi H, Tenma N, Inai M, et al. (July 2016). "Major Anaerobic Bacteria Responsible for the Production of Carcinogenic Acetaldehyde from Ethanol in the Colon and Rectum". Alcohol and Alcoholism. 51 (4): 395–401. doi:10.1093/alcalc/agv135. PMID 26755640.
  32. ^ McGarr SE, Ridlon JM, Hylemon PB (February 2005). "Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature". Journal of Clinical Gastroenterology. 39 (2): 98–109. PMID 15681903.
  33. ^ Hooper SJ, Wilson MJ, Crean SJ (September 2009). Myers JN (ed.). "Exploring the link between microorganisms and oral cancer: a systematic review of the literature". Head & Neck. 31 (9): 1228–1239. doi:10.1002/hed.21140. PMID 19475550. S2CID 27269158.
  34. ^ Russell W (December 1890). "An Address on a Characteristic Organism of Cancer". British Medical Journal. 2 (1563): 1356–1360. doi:10.1136/bmj.2.1563.1356. PMC 2208600. PMID 20753194.
  35. ^ Glover TJ (1926). "Progress in Cancer Research". Canada Lancet and Practitioner. 67: 5.
  36. ^ Patterson RS (1926). "A selected public health bibliography with annotations". American Journal of Public Health. 16 (12): 1242–1244. doi:10.2105/AJPH.16.12.1242. PMC 1581099.
  37. ^ a b Glover TJ (1930). "The bacteriology of cancer". Canada Lancet and Practitioner. 74: 92–111.
  38. ^ Glover TJ, Engle JL (1938). Studies in Malignancy. New York: Murdock Foundation.
  39. ^ a b "Livingston-Wheeler therapy". CA. 40 (2): 103–108. 1990. doi:10.3322/canjclin.40.2.103. PMID 2106368.
  40. ^ Wuerthele-Caspe V, Alexander-Jackson E, Anderson JA, Hillier J, Allen RM, Smith LW (December 1950). "Cultural properties and pathogenicity of certain microorganisms obtained from various proliferative and neoplastic diseases". The American Journal of the Medical Sciences. 220 (6): 638–646. doi:10.1097/00000441-195022060-00006. PMID 14789767. S2CID 39359507.
  41. ^ Livingston VW, Alexander-Jackson E (September 1965). "An experimental biologic approach to the treatment of neoplastic disease; determination of actinomycin in urine and cultures as an aid to diagnosis and prognosis". Journal of the American Medical Women's Association. 20 (9): 858–866. PMID 4220493.
  42. ^ Hess DJ (1997). Can Bacteria Cause Cancer?. New York: NYU Press. ISBN 978-0-8147-3562-6.
  43. ^ L'esperance ES (January 1931). "Studies in Hodgkins Disease". Annals of Surgery. 93 (1): 162–168. doi:10.1097/00000658-193101000-00023. PMC 1398784. PMID 17866459.
  44. ^ Mazet G (June–August 1941). Etude bacteriolgigue sur la maladie d'Hodgkin. Montpellier Medicine.
  45. ^ Von Brehmer W. "Siphonosopra polymorpha n. sp.: ein neuer microorganismus des blutes, seine beziehung zur tumorgenese". Med Welt. 8: 1178–1185.
  46. ^ Crofton WM (1936). The True Nature of Viruses. London, England: Staples Press Ltd.
  47. ^ Villesquez EJ (1955). Le Parasitisme Latent des Cellules du Sang chez l' Homme, en Particulier dans le Sang des Cancreeux. Paris, France: Librarie Maloine.
  48. ^ Fonti CJ (1958). Eziopatogenese del Cancro. Milan, Italy: Amadeo Nicola.& c.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Carcinogenic_bacteria&oldid=1237885850"